Benznidazole in Chagas disease study: do the data justify progression to phase 3?

Lancet Infect Dis. 2021 Aug;21(8):1066-1067. doi: 10.1016/S1473-3099(21)00320-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Chagas Disease* / drug therapy
  • Chagas Disease* / epidemiology
  • Humans
  • Nitroimidazoles* / therapeutic use

Substances

  • Nitroimidazoles
  • benzonidazole